The legal action, spearheaded by Glancy Prongay Wolke & Rotter LLP, centers on allegations that Nano-X executives misled shareholders regarding the company's operational efficiency and market demand. According to the complaint, the firm masked significant issues within its manufacturing processes, which ultimately forced costly restructuring at its Korean chip facility. This misalignment between production output and actual demand reportedly accelerated cash burn and operating expenses, undermining earlier positive statements made to the public. When the company disclosed these setbacks on April 20, 2026, the stock price plummeted to $2.16 per share. Affected shareholders may contact the law firm to pursue recovery claims, though participation in the lawsuit is not mandatory for those who prefer to retain independent counsel or remain as absent class members.